US$ 22.66
bpc 157 tb 500 morning or night BPC-157 + TB-500 Blend Peptide BPC-157 & TB-500 Peptides for
Description
Interstitial Cystitis Study (2024): A preliminary trial in 12 patients with interstitial cystitis (a chronic bladder condition) reported resolution of symptoms in 80 - 100% of participants following BPC-157 treatment

That would materially change long-run dosing math and is worth watching as the Q2 to Q3 2026 TRIUMPH-1 and TRIUMPH-2 readouts arrive
At once-weekly dosing, that is 20 to 40 weeks from a single vial

Seiwerth et al., 2018

New approaches are offering hope where traditional methods max out
